Getting clear on the outcome you're accountable for

• Tell me about the product launch you need manufactured and the business outcome you will be judged on.
• When do you need the first pallet to arrive at distribution or retail? Options: Within 2 weeks, 2-6 weeks, 6-12 weeks, More than 12 weeks, Flexible within quarter
• Who will own daily coordination with the manufacturer and who signs final acceptance? Options: Product manager, Supply chain director, QA lead, Procurement, Other (please name)
• How many SKUs or pack formats must be production-ready at launch? Options: 1 SKU, 2-3 SKUs, 4-6 SKUs, 7+ SKUs
• List the top three sensory or shelf-life targets we must meet, for example taste, texture, and 90-day shelf stability.
• What single outcome short of perfect would cause you to pause the launch rather than ship? Options: Shelf life miss, Safety recall risk, Major sensory fail, Packaging/regulatory noncompliance, Other

Where this usually breaks for teams like yours

• If a co-manufacturer missed your quality standard during peak weeks, describe the immediate business impact you would see.
• When was the last time your team had to re-source a manufacturer, and what broke most during that switch?
• Tell me specifically which parts of that experience you want us to avoid repeating.
• Who inside the organization needs to be alerted first when a quality failure occurs, and how does that change next steps? Options: QA/food safety, Supply chain, Brand/product management, Legal/compliance, Executive leadership
• How often do formulation changes or late ingredient substitutions materially affect finished quality? Options: Almost every launch, Occasionally, Rarely, Never
• Which downstream consequence from a supplier failure would make you stop shipments immediately? Options: Retail pullback, Regulatory hold, Customer complaints/returns, Safety recall, Other

The other paths you're weighing

• Name the other manufacturing or internal options you are actively considering right now. Options: Current incumbent co-manufacturer, Regional co-packer(s), Internal build/expand capacity, Alternate national co-manufacturers, No decision yet
• Which of those alternatives, if unchanged, would keep you with the incumbent for the next 12 months? Options: Price parity, Audit score parity, Guaranteed line allocation, Faster lead times, None of them
• Has anyone on your team proposed solving capacity or quality issues by expanding internal production instead of using an outside partner? Options: Yes, with a timeline, Yes, but no timeline, No one proposed internal build, Undecided
• Approximately how long would an internal build or qualification process take before first production? Options: Less than 3 months, 3-6 months, 6-12 months, More than 12 months
• If price were identical but the incumbent failed your required audit level, would you keep or move suppliers? Options: Keep incumbent, Move to a new partner, Require remediation then decide, Need further internal approval
• What would an alternative partner need to show in a trial or audit to make you switch within your target launch window? Options: SQF/BRC audit result, Successful trial run meeting specs, Named line allocation and schedule, References from similar brands, All of the above

How you'll know the product is ready

• Point to the single metric or test that, if it failed, would lead you to reject a production run. Options: Microbiology test, Sensory panel fail, Shelf-life stability, Allergen control failure, Label/regulatory mismatch
• Describe the lab, sensory, and shelf tests you require, and which are non-negotiable.
• How many samples per batch and which sample ages (day 0, day 30, day 90) do you require for acceptance? Options: 1-3 samples, day 0, 1-3 samples across ages, 5-10 samples across ages, Custom sampling plan
• Who must sign the quality release and what evidence do they expect attached to the release? Options: QA manager signs with lab report, Product manager and QA sign, Procurement and QA sign, Executive sign-off required
• Which labeling, allergen, or regulatory checks will cause a hold at retail or distribution? Options: Incorrect ingredient statement, Allergen mis-declaration, Nutrition panel errors, Country-of-origin noncompliance, Claims/legal issues
• If a trial run meets lab numbers but fails to match your label or retail packaging spec, would you accept a remedial run, delay launch, or stop the project? Options: Remedial run, Delay launch, Stop project, Escalate to legal/retail

Suppliers that could make or break the launch

• Point to the ingredient or packaging item whose shortage would force you to pause production.
• List certifications, country of origin, or supplier approvals that are mandatory for any sourced ingredient or packaging. Options: SQF/BRC-certified supplier, Country-of-origin requirement, Kosher/Halal, Non-GMO/organic, Other
• On average how many approved alternate suppliers do you have for each critical input? Options: None, 1 alternate, 2-3 alternates, 4+ alternates
• Who owns ingredient contracts and will lead negotiations with our procurement team? Options: Procurement, Category manager, Supply chain director, External broker
• Describe any single-supplier relationships or exclusivity clauses that could block us from switching vendors quickly.
• Which scenario would you choose if a long-lead input cannot be sourced within your launch window: accept an approved substitute, delay, or cancel? Options: Accept approved substitute, Delay launch, Cancel project, Escalate to executive decision

Can we actually do this together?

• List the systems, forecast files, and EDI or API connections the seller must integrate with before production scheduling. Options: Forecast file share (CSV), ERP/advance PO feed, EDI ASN, EDI PO only, No integration required
• Name the person who can provide technical drawings, formulation files, and access for line trials.
• Approximately how many internal hours per week can your cross-functional team commit to trial oversight and sign-offs over the next 60 days? Options: Less than 5 hours, 5-10 hours, 10-20 hours, 20+ hours
• Are there contract clauses, legal reviews, or procurement thresholds that historically add more than two weeks to approval timelines? Options: Yes - legal review, Yes - procurement thresholds, Yes - executive approval, No significant delays
• Which facilities or security controls must our staff meet to perform on-site trials or audits? Options: Background check, Visitor badging, Insurance certificate, Confidentiality agreement, None
• What single readiness gap would cause you to pause moving forward until it is resolved? Options: Missing supplier approval, No named production window, Lack of QA release criteria, Contract/legal hold, Other

If everything goes right, how fast can we move?

• If the trial validates your acceptance criteria, what would you need to see to sign an agreement within seven days? Options: Signed MSA terms, Named production dates, Deposit/PO approval, QA acceptance report, All of the above
• Typically how long from signed agreement to first scheduled production day do you expect in your current programs? Options: 1-2 weeks, 2-4 weeks, 4-8 weeks, More than 8 weeks
• Would you accept a phased ramp with initial small runs to qualify lines before full volume, or is full-scale start required? Options: Phased ramp preferred, Full-scale required, Open to either, Depends on category
• Who on your procurement or finance team approves a deposit or first purchase order and what threshold triggers their involvement?
• Which internal concern, if unresolved after trial, would prevent you from placing initial orders even if the product met specs? Options: Budget not released, No line allocation, Legal/contract issues, Retail approval missing, Other

Final red flags and next steps

• Identify the single contractual term, operational fact, or audit result that would make you decline moving forward despite a positive trial.
• Describe the legal or insurance minimums you require, including limits of liability and product recall coverage.
• How do you want us to validate success at 30, 60, and 90 days after launch, and who will own that monitoring? Options: QA-led monitoring, Joint QA and supply chain, Monthly operational review, Retail performance check
• Would you prefer we set a single point acceptance meeting or allow rolling approvals by function as we hit milestones? Options: Single acceptance meeting, Rolling approvals by function, Hybrid approach, Undecided
• If the seller can meet your top three must-haves and provide named operational owners, would you be prepared to issue an LOI or deposit within your target window? Options: Yes, issue LOI or deposit, Maybe, need internal sign-off, No, requires more validation, Unsure

• Solution Walkthrough, Certifications, and Timeline

• Confirm the current state and its cost
• You confirm the seller's certifications and audit history meet your retailer qualification requirements.
• Provide a proposed capacity allocation, named production line, and tentative run dates within 3 business days.
• You confirm the proposed production capability, line allocation, and timeline meet your launch or emergency re-source deadline.
• Verify certifications and audit evidence against your thresholds
• Provide copies of the latest SQF/BRC audit reports, corrective action summaries, and two comparable customer references for similar product categories.
• Map production capabilities to your product and volume needs
• Deliver a detailed trial plan with sampling protocol, acceptance criteria, and contingency decision points for the trial-to-scale conversion.
• You agree on trial acceptance criteria and the specific evidence needed to authorize scale-up and shipment.
• Walk the trial and scale validation plan
• You identify any remaining gaps that would prevent go/no-go within the required timeline.
• Share the final target launch date or required ship-by window, the acceptance criteria you will apply to the trial batch, and any retailer-specific audit thresholds before the trial begins.
• Confirm timeline and material risk mitigations
• Validate that this matches your needed outcome
• Agree next steps and evidence requirements for commercial commit

• Solution Walkthrough Session
• Solution Walkthrough Deck
• Solution Brief — Manufacturing Fit & Timeline

• meeting
• slides
• document

• Pilot formulation scale-up batch
• Short-run production (low-volume runs)
• High-volume production run
• Packaging line setup and changeover
• Packaging procurement and inventory management
• Ingredient sourcing and procurement
• SQF-compliant QA testing and batch release
• Microbiological and shelf-life testing
• Regulatory label review and artwork preparation
• Allergen control and run segregation
• Lot coding, traceability, and recall support
• Co-packing and kitting services
• Cold-chain storage and order fulfillment
• Secure formulation custody under NDA

Pilot formulation scale-up batch

• Specify the target pilot-batch size you need validated (cases, kilograms, or liters). Options: Less than 500 cases, 500-2,500 cases, 2,500-10,000 cases, Other / custom
• Provide the formulation artifacts you will supply for the scale-up (final formula, ingredient spec sheets, Certificate of Analysis).
• List the key sensory and weight tolerances for the product you require during the pilot (e.g., fill weight ±g, flavor profile descriptors).
• How many finished SKUs / pack sizes should the pilot run cover? Options: 1 SKU/pack size, 2-3 SKUs/pack sizes, 4+ SKUs/pack sizes
• Do you require we run a layered sensory panel or only internal QA sensory checks for the pilot batch? Options: Internal QA sensory checks, Buyer-led sensory panel on-site, Third-party sensory panel
• Which acceptance criteria will confirm the pilot formulation scale-up batch meets your product release needs (example: COA, sensory pass, weight tolerance, packaging adhesion)?

Short-run production (low-volume runs)

• Specify the minimum and typical order quantities you anticipate for short-run production (cases per order). Options: Under 1,000 cases, 1,000-5,000 cases, 5,000-10,000 cases, Custom
• Provide the required lead time from PO to ship for low-volume orders. Options: 2 weeks, 3-4 weeks, More than 4 weeks, Flexible
• List the packaging formats and pack counts to support on short-run lines (e.g., 12x12oz jars, 24-pack pouches).
• Identify any secondary services needed for short runs (e.g., secondary packaging, shrink-wrap, custom kitting). Options: Secondary packaging, Kitting, Retail-ready displays, None
• Are there seasonal or promotional windows that will require repeated short-run scheduling? Options: Yes, No
• Who will approve production scheduling conflicts when a short-run competes with higher-volume clients?

High-volume production run

• Specify the annualized or per-run case volumes expected for high-volume production. Options: 10,000-50,000 cases, 50,000-250,000 cases, 250,000+ cases
• Provide your required on-shelf launch date and any hard blackout dates for production.
• List target line speeds or cycle times critical to your cost model (e.g., fill CPM, cases per minute).
• How many fill/packaging lines must be allocated or reserved to meet your ramp schedule? Options: One line, Two lines, Three or more
• Identify any specialized equipment or setpoints required on high-volume lines (e.g., hot-fill, aseptic, MAP—modified atmosphere packaging).
• Who will own change-control for formula adjustments during high-volume ramp? Options: You (buyer) approve changes, We (manufacturer) propose changes with buyer approval, Joint approval

Packaging line setup and changeover

• Specify the average changeover time tolerance acceptable for your SKU family (minutes or hours). Options: Under 1 hour, 1-4 hours, More than 4 hours
• Provide a list of packaging components that require new tooling or special fixtures (cap type, neck finish, carton die).
• List the statutory label elements that must be present after changeover (Nutrition Facts panel, allergen statement, lot code placement).
• How many back-to-back SKUs require single-day changeover capability? Options: None, 1-2 SKUs, 3+ SKUs
• Are there required run-segregation steps during changeover for allergen or GMP reasons? Options: Yes, No
• Who will sign off that the line is ready post-changeover (role/title)?

Packaging procurement and inventory management

• Provide the preferred packaging lead times you can accept for primary and secondary materials. Options: 1-2 weeks, 3-6 weeks, More than 6 weeks
• List any packaging specifications or supplier QC docs you will supply (material spec, print approvals, color targets).
• Indicate whether you require vendor-managed inventory (VMI) for packaging components. Options: Yes, full VMI, Partial VMI, No, buyer-managed
• Estimate target safety stock levels in cases or units for critical packaging SKUs.
• Are there mandated print run QA checks (e.g., color match report, barcode verification) you require on receipt? Options: Yes, No
• Who will own replenishment cadence and approval of packaging POs? Options: You (buyer), We (manufacturer), Shared process

Ingredient sourcing and procurement

• Provide a bill of materials (BOM) or list of critical ingredients including supplier and minimum spec for each.
• Indicate if any ingredients require specialty sourcing (ethically certified, organic, hydrocolloids, allergens). Options: Yes, organic/verified, Yes, allergen-controlled, No special sourcing
• List required Certificate of Analysis (COA) test panels and acceptable limits for critical ingredients.
• How many days of ingredient lead time are acceptable for continuity of production? Options: 7-14 days, 15-30 days, 30+ days
• Are you able to approve alternate suppliers subject to our supplier qualification process? Options: Yes, pre-approved alternates allowed, No, only approved suppliers
• Who will own raw-material traceability exceptions and supplier escalation contact?

SQF-compliant QA testing and batch release

• Provide the SQF or other food safety evidence you require for each batch (audit score, site CAPA reports).
• Detail the minimum Certificate of Analysis (COA) tests required on finished product before release (e.g., solids, pH, Brix).
• Confirm the acceptance criteria that will authorize batch release under your program (examples: negative pathogen PCR, COA within limits, environmental swab results).
• Are third-party laboratory testing or buyer-directed hold-and-release steps required prior to shipping? Options: Yes, third-party required, Internal lab acceptable, Hybrid approach
• Identify required QA documentation to be delivered with each lot (batch record, COA, shelf-life certificate).
• Who at your organization will be the authorized signatory for batch acceptance and release?

Microbiological and shelf-life testing

• Specify required microbiological tests and acceptance limits for finished goods and environmental monitoring (e.g., APC, yeast/mold, Listeria absence).
• Provide target shelf-life (days/months) and required storage condition to validate (ambient, refrigerated, frozen). Options: Ambient (room temp), Refrigerated (2-8°C), Frozen (<-18°C)
• List any accelerated stability or challenge test protocols you require for shelf-life claims.
• Are third-party accredited labs mandated for microbiology or shelf-life validation? Options: Yes, No
• How many production lots must pass shelf-life testing before you consider long-run approval? Options: One lot, 2-3 lots, 3+ lots
• Who will own acceptance of shelf-life test exceptions and label-date adjustments?

Regulatory label review and artwork preparation

• Provide the target markets and regulatory regimes for the label (e.g., federal nutrition rules, state allergen labeling, export markets).
• Indicate required label artifacts you will supply (approved Nutrition Facts panel, ingredient statement, allergen declaration, UPC).
• List the file formats and color specifications required for final artwork acceptance (PDF/X, Pantone callouts).
• Confirm the acceptance criteria that will authorize final artwork and label approval (e.g., verified Nutrition Facts, barcode scan success, regulatory sign-off).
• Are you requiring GS1 barcode verification or specific lot-code placement rules for retail scanning? Options: GS1 verification required, Standard barcode acceptable, Buyer will verify separately
• Who at your organization will provide final regulatory sign-off on label copy?

Allergen control and run segregation

• Identify all declared and potential cross-contact allergens in your formulation (e.g., milk, soy, tree nuts).
• Indicate whether dedicated lines or validated flushes are required between allergen and non-allergen runs. Options: Dedicated lines required, Validated flush/cleaning acceptable, Case-by-case
• Describe any allergen testing or environmental swab frequency you require during runs.
• Are there specific labeling or segregation rules for non-GMO, gluten-free, or other dietary claims tied to allergen control? Options: Yes, No
• When segregation is needed, estimate additional changeover or hold time you will accept. Options: Under 2 hours, 2-8 hours, Over 8 hours
• Who will approve the allergen-control SOP and any exceptions?

• current_state
• success_criteria
• stakeholders
• gaps
• desired_state
• decision_readiness
• current_state
• decision_readiness
• stakeholders
• desired_state
• success_criteria
• gaps
• desired_state
• stakeholders
• gaps
• decision_readiness
• success_criteria
• current_state
• decision_readiness
• decision_readiness
• decision_readiness
• decision_readiness

• Master Manufacturing Services Agreement (MSA)
• Statement of Work (SOW)
• Order Confirmation & Commercial Terms
• Quality & Acceptance Criteria Addendum
• Intellectual Property & Confidentiality Agreement
• Insurance, Indemnity & Recall Allocation Schedule
• Supply & Ingredient Sourcing Schedule
• Change Order Agreement
• Trial Batch Acceptance Report
• Regulatory & Retailer Audit Compliance Annex

• Go-live Health Check (Weeks 1-4)
• First Production Measurement (Weeks 4-10)
• 90-Day Performance Review and Remediation Closeout
• Ongoing Quarterly Production Review

• Document supplier risk mitigation actions and confirm new lead-time commitments in writing.
• All critical remediation items are closed or have committed resolution dates and verification plans.
• Quality deviation rate and time-to-resolution meet the targets recorded in Manufacturing Scope and Launch Acceptance, or have an agreed remediation timetable.
• Sampling protocol and acceptance criteria confirmed for ongoing monitoring.
• Publish remediation closure evidence and results of validation sampling.
• Schedule any required follow-up validation runs and define success criteria for each run.
• Update QA acceptance checklist and monitoring frequency based on validation findings.
• Production performance trends
• Confirm on-time delivery rate and customer complaint rate per 10,000 units are at or moving toward the targets recorded in Manufacturing Scope.
• Prioritized continuous improvement backlog with timelines for the next quarter.
• Identified supply risks mitigated or assigned owners with mitigation plans.
• Publish the quarterly performance dashboard showing metric trends and variances against Manufacturing Scope targets.
• Produce prioritized improvement plan for items approved this quarter with expected delivery windows.
• Reconfirm success criteria and named owners
• All success criteria and their owners documented and confirmed in Manufacturing Scope and Launch Acceptance.
• Initial production batch validated with QA sampling completed and documented.
• Incumbent system decommissioning plan or read-only/archive plan recorded and scheduled.
• Publish the go-live validation report including deviations and immediate remediation tasks.
• Document the incumbent decommissioning or archive schedule and retention details.
• Capture remediation tasks with target resolution dates and distribute to stakeholders for acknowledgement.
• Present production and quality data
• Determine whether batch acceptance rate and first-pass quality yield are trending toward the targets recorded in Manufacturing Scope and Launch Acceptance.
• Documented corrective action plan with timelines to restore metrics to target range.
• Confirmation of supplier lead-time alignment or documented mitigation for shortfalls.
• Produce a root-cause analysis for any failed or marginal batches with proposed corrective actions.
• Update the production schedule to reflect corrective actions and re-measure windows.
• Obtain written supplier lead-time confirmations for critical ingredients and packaging components.
• Review remediation status and closure evidence
• Deployment and first-run validation
• Present performance versus targets
• Supply continuity and inventory readiness
• Root-cause diagnosis for gaps
• Continuous improvement backlog review
• Agree corrective actions and timelines
• Early adoption and operational signals
• Validate corrective action effectiveness
• Confirm supply and packaging continuity
• Agree residual actions and monitoring cadence
• Open issues and escalation review
• Incumbent decommissioning and fallback closure
• Blockers and immediate remediation actions